Two Sigma Investments’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.32M | Buy |
366,612
+114,863
| +46% | +$414K | ﹤0.01% | 2042 |
|
2025
Q1 | $753K | Sell |
251,749
-34,172
| -12% | -$102K | ﹤0.01% | 2273 |
|
2024
Q4 | $958K | Sell |
285,921
-55,840
| -16% | -$187K | ﹤0.01% | 2148 |
|
2024
Q3 | $1.14M | Sell |
341,761
-33,314
| -9% | -$112K | ﹤0.01% | 1988 |
|
2024
Q2 | $1.24M | Buy |
375,075
+2,825
| +0.8% | +$9.35K | ﹤0.01% | 1804 |
|
2024
Q1 | $1.5M | Buy |
372,250
+210,341
| +130% | +$850K | ﹤0.01% | 1637 |
|
2023
Q4 | $494K | Buy |
161,909
+107,813
| +199% | +$329K | ﹤0.01% | 2388 |
|
2023
Q3 | $162K | Sell |
54,096
-121,084
| -69% | -$363K | ﹤0.01% | 2600 |
|
2023
Q2 | $655K | Buy |
+175,180
| New | +$655K | ﹤0.01% | 2123 |
|
2022
Q4 | – | Sell |
-98,482
| Closed | -$560K | – | 2739 |
|
2022
Q3 | $560K | Sell |
98,482
-12,035
| -11% | -$68.4K | ﹤0.01% | 1677 |
|
2022
Q2 | $785K | Sell |
110,517
-491,485
| -82% | -$3.49M | ﹤0.01% | 1592 |
|
2022
Q1 | $4.35M | Sell |
602,002
-187,663
| -24% | -$1.35M | 0.01% | 957 |
|
2021
Q4 | $7.06M | Buy |
+789,665
| New | +$7.06M | 0.02% | 781 |
|